

An Animal’s Size And Its Cancer Risk | Bastetodon, A 30 Million-Year-Old Apex Predator
Mar 4, 2025
Dr. Sarah Amand, an Associate Professor at Johns Hopkins, challenges Peto's Paradox, which maintains that larger animals don’t have higher cancer risk. She reveals fresh findings suggesting that larger species might actually face increased cancer rates. The conversation also explores the fascinating traits of cancer-resistant animals like elephants. Additionally, a remarkable fossil of Bastetodon, a 30-million-year-old predator, is unveiled, connecting ancient ecological dynamics to cultural history.
AI Snips
Chapters
Transcript
Episode notes
Peto's Paradox Challenged
- Peto's Paradox, an observation by Richard Peto, stated that larger animals don't have higher cancer risks than smaller ones.
- New research challenges this paradox, finding that larger species actually show a greater cancer prevalence.
Zoo Data Challenges Paradox
- A new study using zoo death reports reveals Peto's Paradox may be false.
- Larger species demonstrate an increased cancer prevalence, contrary to the paradox.
Elephant Cancer Resistance
- Elephants, despite their size, exhibit some cancer resistance.
- They possess multiple copies of the P53 tumor suppressor gene, offering higher protection.